Literature DB >> 11590506

Guidelines for the use of antiretroviral agents in pediatric HIV infection, January 7, 2000.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11590506     DOI: 10.1310/hct.2000.1.3.007

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


× No keyword cloud information.
  93 in total

Review 1.  Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.

Authors:  A Bardsley-Elliot; C M Perry
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

2.  Nevirapine: an option for preventing as well as treating paediatric HIV infection.

Authors: 
Journal:  Afr Health Sci       Date:  2001-08       Impact factor: 0.927

3.  Single-dose safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, in HIV-infected children.

Authors:  Ram Yogev; Andrea Kovacs; Ellen G Chadwick; James D Homans; Yu Lou; William T Symonds
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children.

Authors:  Carina A Rodriguez; Sarah Koch; Maureen Goodenow; John W Sleasman
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Antiretroviral Stewardship in a Pediatric HIV Clinic: Development, Implementation and Improved Clinical Outcomes.

Authors:  Alice J Hsu; Asha Neptune; Constants Adams; Nancy Hutton; Allison L Agwu
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

6.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

7.  Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.

Authors:  Paul Krogstad; Kunjal Patel; Brad Karalius; Rohan Hazra; Mark J Abzug; James Oleske; George R Seage; Paige L Williams; William Borkowsky; Andrew Wiznia; Jorge Pinto; Russell B Van Dyke
Journal:  AIDS       Date:  2015-03-27       Impact factor: 4.177

8.  Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

9.  Virologic testing in infants with perinatal exposure to HIV receiving multidrug prophylaxis.

Authors:  Maureen D Connolly; Richard M Rutstein; Elizabeth D Lowenthal
Journal:  Pediatr Infect Dis J       Date:  2013-02       Impact factor: 2.129

10.  Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.

Authors:  Richard S B Wanless; Sorin Rugină; Simona Maria Ruţă; Irina-Magdalena Dumitru; Roxana Carmen Cernat; Heidi L Schwarzwald; Nancy R Calles; Gordon E Schutze; Ana-Maria Schweitzer; Heather R Draper; Mark W Kline
Journal:  Germs       Date:  2013-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.